Mutual Recognition among SG-MY-TH: How to Choose Your First Launch Route for Southeast Asia Market Layout
Views:85
Time:2026-11-09 13:56:27


The Southeast Asia medical device market keeps expanding. As core ASEAN markets, Singapore, Malaysia and Thailand have rolled out mutual recognition frameworks, bringing great opportunities for overseas manufacturers to cut registration timelines and compliance costs significantly. The trilateral recognition system is not a universal one-certificate scheme. Instead, it combines mutual bilateral recognition and unilateral reliance. Your choice of the first launch market directly shapes your ASEAN go-to-market timeline. This article fully unpacks the mutual recognition rules, application pathways and compliance essentials for Singapore HSA, Malaysia MDA and Thailand TFDA.



一、Overview of the Trilateral Recognition Mechanism



Three sets of regulatory recognition relationships apply:
(一)Singapore ↔ Malaysia: Mutual Recognition

Regulators: Singapore HSA & Malaysia MDA 

Pilot Period: Sep 2025 – Feb 2026 

Official Effective Date: Mar 01, 2026 

Reference Document: MDA/GD/0070 Guidance 

Key Implication: Singapore and Malaysia mutually accept each other’s registration outcomes, marking a milestone for market integration. Once you obtain approval from either authority, you may apply to the other via the simplified mutual recognition route without a full repeated review.


(二)Malaysia ↔ Thailand: Mutual Recognition
Regulators: Malaysia MDA & Thailand TFDA

Pilot Period: Dec 2025 – Feb 2026 

Official Effective Date: May 01, 2026 Reference Document: Regulatory Reliance Programme Guidance 

Key Implication: Mutual recognition between Malaysia and Thailand is established. With a registration certificate issued by either authority, you can submit a simplified application to the other.


(三)Thailand Recognises Singapore: Unilateral Reliance
Regulators: Singapore HSA → Thailand TFDA
Rule: Only Thailand accepts Singapore registration. The reverse does NOT apply; Singapore does not recognise Thailand approvals.

Scope: Covers all HSA Class B/C/D medical devices since 2022 

Core Benefit: The reliance route waives expert review, shortening registration timelines by 1–3 months. Mandatory Condition: The technical dossier submitted to Thailand must be identical to the version approved in Singapore.


二、Three Launch Sequencing Strategies



Route 1: Malaysia First

Workflow: Secure Malaysia MDA registration first, then apply to Singapore and Thailand under mutual recognition. 

Strengths: Malaysia registration undergoes dual assessment: CAB conformity assessment plus MDA review. Malaysia certificates carry strong credibility, serving as a solid foundation for subsequent reliance and mutual recognition applications in Singapore and Thailand. Ideal for manufacturers of high-risk devices with a risk-averse strategy.


Route 2: Thailand First

Workflow: Submit to Thailand TFDA under the Reliance pathway for fast approval; use the Thailand clearance to apply for Malaysia mutual recognition, then proceed to Singapore. 

Strengths: Thailand’s Reliance route exempts expert evaluation, cutting lead time by 1–3 months. Suitable for teams aiming to obtain the first ASEAN approval quickly and capture the Thailand market ahead of competitors.


Route 3: Parallel Malaysia + Thailand Submission

Workflow: File applications in Malaysia and Thailand simultaneously, obtain two approvals that serve as cross-reference evidence, then submit to Singapore. 

Strengths: Shortest overall timeline. Holding two independent ASEAN approvals mitigates risks such as supplementary queries or review delays in a single jurisdiction. Suitable for well-funded companies seeking rapid multi-market entry.


三、Application Process & Non-negotiable Prerequisites



Mutual recognition does not mean automatic market access with an existing certificate. Standardised workflows and hard requirements must be followed:
(一)Singapore / Thailand → Malaysia

Prerequisite: Valid Singapore or Thailand registration for medium-to-high risk devices 

Submission Channel: Dedicated MDA verification channel, no repeated testing required 

Review Scope: MDA verifies registration authenticity and alignment with local Malaysian regulatory requirements 

Advantage: MDA Verification Route eliminates repeat clinical evaluation, with lower time and cost compared to a full standalone application.


(二)Malaysia → Singapore / Thailand

Prerequisite: Valid Malaysia MDA medical device registration certificate 

Submission Channel: Simplified mutual recognition channels of Singapore and Thailand 

Review Scope: Target regulators verify dossier compliance 

Advantage: One MDA cailandertificate supports simplified filings for both Singapore and Th.


Three Mandatory Core Requirements:
  1. Application Route: File via the MDA Verification Route; no repeated clinical evaluation
  2. Product Consistency: Design, specifications and intended use must be identical to the version approved in the reference market
  3. Submission Portal: All Malaysia submissions are via the MeDC@St system, with verification performed by an MDA-recognised CAB.

四、Side-by-Side Comparison of Registration Requirements


Comparison ItemSingapore HSAThailand TFDAMalaysia MDA
Risk ClassificationClass A/B/C/DClass 1–4Class A/B/C/D
Registration PathwaysFull / Simplified / Expedited / ImmediateFull / Simplified / RelianceCAB Conformity Assessment + MDA Registration
High-Risk RulesClass D: EDR requires ≥2 reference country approvalsClass 3/4: Expert review normally required; Reliance route exempts reviewClass C/D: Mandatory full CAB assessment
Submission PlatformMEDICSTFDA online portalMeDC@St
Technical DocumentationASEAN CSDTCSDT + reference country approval evidenceMDA CSDT + Annex B/C Declarations
Certificate Validity5 years, SMDR annual retention5 years, annual renewal window5 years, full re-registration (including CAB reassessment)
Reference Country MechanismDetermines review scope and intensityBasis for simplified / reliance eligibilityFoundation for mutual recognition and verification routes
五、Post-Approval Compliance Maintenance Checklist



Many manufacturers face certificate invalidation due to neglected post-market obligations:
Compliance ItemSingaporeThailandMalaysia
Certificate Validity5 years (listed in SMDR)5 years5 years
Renewal RulesComplete SMDR annual retentionAnnual window: Oct 1 – Feb of next year; prepare 90 days before expiryFull re-registration including CAB reassessment; plan 1 year in advance
LabellingConsistent with registered informationNon-professional devices require Thai language; Thai representative information on outer packagingMDA certificate number marked on labelling
Change ManagementGN-21 notification; changes affecting safety, quality or performance require submissionCategorised change submission; some changes require TFDA approval prior to implementation3-tier classification: Minor / Major / Re-registration; MDA approval required for certain changes
Import ArrangementDistributor fulfils HPTA obligationsImport must be conducted by the Thai Certificate HolderGDPMD certificate + MDA licence + LOA authorisation
VigilanceAdverse event monitoring; FSCA may suspend reviewPost-market surveillance & vigilance reportingPost-market surveillance & adverse event reporting
六、Closing Remarks



The launch of SG-MY-TH mutual recognition is a major compliance dividend for ASEAN medical device manufacturers. Nevertheless, the framework is layered, mixing unilateral and bilateral arrangements. Your initial market choice directly controls project lead time and risk.Wiselink Group — Your trusted partner for global market access!



Contact Us
Fill Form
Whether you need more information or wish to cooperate with us, we will guide you through every step of the regulatory process. Subscribe to our newsletter for the latest global regulatory updates.